The Australia Sleep Apnea Oral Appliances Market was valued at $3.2 Million in 2025 and projected to reach to $5.2 Million by 2030, representing a compound annual growth rate of 10.2%. Australia's sleep apnea oral appliances market is positioned for sustained growth through 2030, driven by heightened awareness of obstructive sleep apnea and the therapeutic benefits of oral appliances.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Australia's sleep apnea oral appliances market is valued at $3.2 million in 2025, with projections reaching $5.2 million by 2030, representing a robust 10.2% CAGR over the forecast period.
Increasing diagnosis rates of obstructive sleep apnea across Australia are driving demand for oral appliances as healthcare providers and patients seek non-invasive treatment alternatives to traditional CPAP therapy.
Australian patients increasingly prefer oral appliances due to improved comfort and compliance compared to CPAP devices, positioning them as a viable first-line or alternative treatment option in the local market.
Australia's market CAGR of 10.2% exceeds the global average of 9.8%, indicating stronger regional adoption and market penetration of oral appliance technology within the Australian healthcare system.
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | ONLINE PHARMACIES (Distribution Channel) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 9.8% from 2025 to 2030 |
| Largest Segment | MANDIBULAR ADVANCEMENT DEVICES (Product) |
| Market Size Base Year (Billions) | ~USD 0.5 (2025) |
| Revenue Forecast (Billions) | ~USD 0.8 (2030) |
| Segments Covered | Product, Type, Purchase Type, Gender, Age Group, Distribution Channel, End User |
7 segment dimensions are covered across the global market.
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| DENTAL CLINICS | 0.3 | 0.3 | 0.3 | 0.4 | 0.4 | 0.5 | 0.5 | 0.6 | 8.4 |
| HOME CARE SETTINGS/INDIVIDUALS | 1.8 | 2 | 2.1 | 2.4 | 2.6 | 3.1 | 3.5 | 3.9 | 10.4 |
| HOSPITALS | 0.6 | 0.7 | 0.8 | 0.8 | 0.9 | 1.1 | 1.2 | 1.3 | 10.2 |
| TOTAL | 2.7 | 3 | 3.2 | 3.6 | 3.9 | 4.7 | 5.2 | 5.8 | 10.1 |
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| LIVANOVA PLC | United Kingdom | Public Company | Mandibular Advancement Devices (MAD),Tongue-Retaining Devices (TRD),Implantable Sleep Apnea Neuromodulation (aura6000), |
| COLGATE | United States | Public Company | Mandibular Advancement Devices (MAD),Tongue-Retaining Devices (TRD),Physician-prescribed (all products), |
| SOMNOMED | Australia | Public Company | Mandibular Advancement Devices (SomnoDent Avant, Classic, Flex, Fusion and related MADs),Tongue-Retaining Devices (TRD) and other oral sleep devices,Adjacencies (SomMorning Repositioner, SomnoBrux splints, SomTabs and accessories), |
| RESMED | United States | Public Company | Mandibular Advancement Devices (MAD),Tongue-Retaining Devices (TRD),Physician-prescribed (all oral appliances), |
| PROSOMNUS SLEEP TECHNOLOGIES | United States | Private Company | Mandibular Advancement Devices (MAD),Tongue-Retaining Devices (TRD),Other custom intraoral OSA devices / accessories, |
| VIVOS THERAPEUTICS, INC. | United States | Public Company | Mandibular Advancement Devices (MAD),Tongue-Retaining Devices (TRD),Physician-prescribed programs and services (screening, home sleep test, treatment planning), |
| ORAVANOSA | Mandibular Advancement Devices (MAD),Tongue-Retaining Devices (TRD),Physician-prescribed channel, |
LivaNova PLC is a United Kingdom-based medical device company founded in 2015 with 3,300 employees. Operating as a public company, it develops innovative healthcare solutions.
Colgate is a United States-based consumer goods company founded in 1806 with 33,600 employees. As a public company, it is a global leader in oral care and personal hygiene products.
SomnoMed is an Australian medical device company founded in 1987 with 300 employees. Operating as a public company, it specializes in sleep and respiratory solutions.
ResMed is a United States-based medical device and software company founded in 1989 with 10,600 employees. As a public company, it focuses on digital health and cloud-connected medical devices.
ProSomnus Sleep Technologies is a United States-based private company founded in 2016 with 136 employees. It develops innovative solutions for sleep and airway management.
Vivos Therapeutics, Inc. is a United States-based public company founded in 2016 with 270 employees. It develops medical devices and therapeutics for sleep apnea and airway management.
Insufficient data available for company description.
Australia's sleep apnea oral appliances market was valued at $3.2 million in 2025 and is projected to grow to $5.2 million by 2030.
Australia's market is expected to grow at a compound annual growth rate (CAGR) of 10.2% from 2025 to 2030, outpacing the global average.
Australia's above-average growth is driven by increasing OSA awareness, an aging population, strong healthcare infrastructure, and rising patient preference for non-invasive treatment alternatives.
Australia utilizes mandibular advancement devices (MADs), tongue-retaining devices, and other custom-fitted oral appliances as alternatives to CPAP therapy for sleep apnea treatment.
Dental professionals, sleep medicine specialists, and respiratory physicians in Australia collaborate to prescribe and fit oral appliances for sleep apnea patients.
This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.
The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, investor presentations, SEC filings of companies and publications from government sources [such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), Global Burden of Disease Study, and Centers for Medicare and Medicaid Services (CMS) were referred to identify and collect information for the global sleep apnea oral appliances market study. It was used to gather vital information about key players, classify and segment the market according to industry trends, down to the most detailed level, and highlight key developments related to market and technological perspectives. A database of the key industry leaders was also prepared using secondary research.
In the primary research process, we interviewed various supply and demand sources to gather qualitative and quantitative information for this report. The supply-side sources included industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and other key executives from prominent companies and organizations within the sleep apnea oral appliances market. On the demand side, we gathered insights from sleep clinics, dental clinics, hospitals, and academic institutions. This primary research was conducted to validate market segmentation, identify key players in the industry, and gain insights into important industry trends and market dynamics.
A breakdown of the primary respondents is provided below:
Note 1: C-level primaries include CEOs, CFOs, COOs, and VPs.
Note 2: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note 3: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = < USD 1.00 billion.
Source: MarketsandMarkets Analysis
To know about the assumptions considered for the study, download the pdf brochure
For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global sleep apnea oral appliances market. All the leading service providers were identified at the global/country/regional level. Revenue mapping for the respective business segments/subsegments was conducted for the major players. Also, the global sleep apnea oral appliances market was split into various segments and subsegments based on the following:
The above data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

After arriving at the overall size of the global sleep apnea oral appliances market through the methodology mentioned above, this market was split into several segments and subsegments. Where applicable, the data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both demand- and supply-side participants.
Sleep apnea is a common sleep disorder that usually goes undiagnosed but has severe and life-threatening effects. The most common type of sleep apnea is obstructive sleep apnea. Due to patient non-compliance with positive airway pressure (PAP) devices, oral appliances are gaining popularity in treating sleep apnea. Oral appliance therapy (OAT) treats snoring and obstructive sleep apnea (OSA) patients. OAT can be an effective treatment for patients who prefer oral appliances over continuous positive airway pressure (CPAP) or those unable to tolerate CPAP.
Full forecast, segment splits, and company analysis for all Sleep Apnea Oral Appliances Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report